All Resources

Access to Medicine • May 06, 2025

Canadian Drug Access Pathway

Learn more | View

Patented Medicine Prices Review Board (PMPRB) • January 04, 2024

IMC Response to the PMPRB’s 2023 Scoping Paper for the Consultations on the Board’s Guidelines

Learn more | View

Access to Medicine • August 21, 2023

pCPA Temporary Access Process: Innovative Medicines Industry Consultation Response

Learn more | View

Pharmacare • June 01, 2023

Addendum to Innovative Medicines Canada Submission on National Pharmacare

Learn more | View

March 08, 2023

Ontario PreBudget Submission

Learn more | View

Access to Medicine • February 15, 2023

Increasing Access to Innovative Medicines

Learn more | View

Economic Impact • October 07, 2022

Pre-Budget Consultations in Advance of the 2023 Budget

Learn more | View

April 28, 2022

Reflections on a Potential Pan-Canadian Drug Formulary: Medicines Industry Response to CADTH Consultation

Learn more | View

Access to Medicine • February 12, 2022

Optimizing Patient Access to Precision Therapies: Preparing for the Emerging Era of Advanced Testing

Learn more | View

Access to Medicine • February 05, 2022

Bluesky Project

Reimagining Canada’s Approval and Reimbursement System for Innovative Medicines February 2022…

Learn more | View

January 14, 2022

2022 Ontario Pre-Budget Consultation

Learn more | View

Drugs for Rare Diseases (DRD) • September 15, 2021

Addendum to IMC Submission on Drugs for Rare Diseases

Learn more | View